SINGAPORE - The Agency for Care Effectiveness (ACE) is not just assessing the relative merit of drugs, but also doing its bit to stop insurance premiums from spiking out of reach.
It was in the limelight recently for its Cancer Drug List (CDL). From September 2022, MediShield Life and MediSave stopped covering treatments not on the list.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
